Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 8 | -$0.03 | -$0.02 | -$0.02 |
Q2 2025 | 5 | -$0.02 | -$0.01 | -$0.02 |
Q3 2025 | 4 | -$0.02 | -$0.01 | -$0.01 |
Q4 2025 | 5 | -$0.01 | -$0.01 | -$0.01 |
Q1 2026 | 3 | -$0.03 | -$0.02 | -$0.02 |
Q2 2026 | 4 | -$0.02 | -$0.02 | -$0.02 |
Q3 2026 | 3 | -$0.01 | -$0.01 | -$0.01 |
Q4 2026 | 4 | -$0.01 | -$0.01 | -$0.01 |
Maravai LifeSciences Holdings, Inc. last posted its earnings results on Tuesday, February 25th, 2025. The company reported $-0.05 earnings per share for the quarter, missing analysts' consensus estimates of $-0.03 by $0.02. The company had revenue of 65.20 M for the quarter and had revenue of 288.95 M for the year. Maravai LifeSciences Holdings, Inc. has generated $-1 earnings per share over the last year ($-0.9 diluted earnings per share) and currently has a price-to-earnings ratio of -1.64. Maravai LifeSciences Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/12/2024 | Q3 2024 | N/A | -$0.70 | N/A | $67.55 M | $65.20 M |
08/08/2024 | Q2 2024 | N/A | -$0.06 | N/A | $71.92 M | $73.40 M |
05/09/2024 | Q1 2024 | N/A | -$0.09 | N/A | N/A | $64.18 M |
02/29/2024 | Q4 2023 | N/A | -$0.80 | N/A | N/A | $74.14 M |
11/08/2023 | Q3 2023 | N/A | -$0.05 | N/A | $75.47 M | $66.87 M |
08/08/2023 | Q2 2023 | N/A | -$0.05 | N/A | $71.10 M | $68.91 M |
05/09/2023 | Q1 2023 | N/A | -$0.01 | N/A | N/A | $79.03 M |
02/28/2023 | Q4 2022 | N/A | $0.66 | N/A | N/A | $204.71 M |
11/03/2022 | Q3 2022 | N/A | $0.76 | N/A | $195.11 M | $191.26 M |
08/05/2022 | Q2 2022 | N/A | $0.61 | N/A | $233.22 M | $242.73 M |
05/06/2022 | Q1 2022 | N/A | $0.58 | N/A | N/A | $244.29 M |
03/01/2022 | Q4 2021 | N/A | $0.42 | N/A | N/A | $228.44 M |
11/12/2021 | Q3 2021 | N/A | $0.46 | N/A | $201.50 M | $204.81 M |
08/11/2021 | Q2 2021 | N/A | $0.44 | N/A | $194.81 M | $217.78 M |
05/12/2021 | Q1 2021 | N/A | $0.24 | N/A | N/A | $148.21 M |
03/22/2021 | Q4 2020 | N/A | $0.60 | N/A | N/A | $98.35 M |
09/29/2020 | Q3 2020 | N/A | $0.44 | N/A | N/A | $87.86 M |
06/29/2020 | Q2 2020 | N/A | $0.00 | N/A | N/A | $46.91 M |
03/30/2020 | Q1 2020 | N/A | $0.26 | N/A | N/A | $50.98 M |
12/30/2019 | Q4 2019 | N/A | -$0.06 | N/A | N/A | $35.96 M |
Maravai LifeSciences Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based offlast year's report dates.
The conference call for Maravai LifeSciences Holdings, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Maravai LifeSciences Holdings, Inc.'s latest earnings report can be read online.
Maravai LifeSciences Holdings, Inc. (:MRVI) has a recorded annual revenue of $288.95 M.
Maravai LifeSciences Holdings, Inc. (:MRVI) has a recorded net income of $-119,029,000.Maravai LifeSciences Holdings, Inc. has generated $-0.9 earnings per share over the last four quarters.
Maravai LifeSciences Holdings, Inc. (:MRVI) has a price-to-earnings ratio of -1.64 and price/earnings-to-growth ratio is 0.03.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED